
NYSE:MET
This summary was created by AI, based on 1 opinions in the last 12 months.
Metlife (symbol: MET-N) has recently achieved a 52-week high, showcasing its resilience and strong market position. The reviews indicate that the company is perceived as solid, conservative, and defensive, which are attractive attributes for risk-averse investors. These characteristics suggest that Metlife is well-invested in the right areas, possibly focusing on stable and sustainable growth. The consistent performance underscores a trustworthy investment option, leading experts to feel confident in its future prospects. Overall, the expert reviews reflect an appreciation for Metlife’s prudent management and strategic choices in navigating market conditions.
Metlife is a American stock, trading under the symbol MET (previously MET-N on Stockchase) on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MET (previously MET-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Metlife.
Metlife was recommended as a Top Pick by Brian Acker, CA on 2019-06-14. Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Metlife.
Metlife is followed by 36 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-06, Metlife (MET) stock closed at a price of $90.82.
Just made a 52-week high. Solid, conservative and defensive, invested in the right things.